On March 1, the U.S. Food and Drug Administration (FDA) released a safety communication consisting of updated commendations concerning drug-drug interactions between statins and protease inhibitors. Taking the two types of drugs can increase the blood level of the statin and increase the risk for myopathy, including rhabdomyolysis. Read more.
© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.